- Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. Delgado, J., Thomson, K., Russell, N., Ewing, J., Stewart, W., Cook, G., Devereux, S., Lovell, R., Chopra, R., Marks, D.I., Mackinnon, S., Milligan, D.W. Blood (2006)